Biotechnology Cardiology Clinical Trials Coronavirus Coronavirus COVID-19 drug development Infectious Diseases rare diseases Potential new drug to mitigate SARS-CoV-2 infection consequences By Staff Reports 4 months ago Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Infectious Diseases rare diseases Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting By Staff Reports 4 months ago Eli Lilly and Company said proof of concept data from an interim analysis of the
Biotechnology cancer CU Researchers Come Together to Better Understand Ovarian Cancer Tumors and Treatment Outcomes By Staff Reports 4 months ago After nearly four years of work, a group of researchers and clinicians from the University
Biotechnology Centers for Disease Control Clinical Trials Coronavirus Coronavirus COVID-19 Infection Control Infectious Diseases rare diseases Vaccines Antibody responses in COVID-19 patients could guide vaccine design By Staff Reports 4 months ago A comprehensive analysis of antibody responses in coronavirus disease 2019 (COVID-19) patients could inform the
Biotechnology Breast Cancer cancer Clinical Trials Scientists Identify New Way To Target Some Rapidly Dividing Cancer Cells, Leaving Healthy Cells Unharmed By Staff Reports 4 months ago Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 rare diseases Vaccines Preclinical study of COVID-19 vaccine candidate shows potent T-cell responses By Staff Reports 5 months ago Preclinical studies of a COVID-19 vaccine candidate at the University of Alabama at Birmingham show
Biotechnology cancer Clinical Trials drug development New Treatment Developed by Children’s Hospital of Philadelphia Shows Success in High-Risk Solid Tumors By Staff Reports 5 months ago Despite intensive treatment, high-risk solid tumors like neuroblastoma, Ewing sarcoma, and rhabdomyosarcoma are challenging to
Biotechnology cancer Clinical Trials Targeted therapy combination effective for patients with advanced cholangiocarcinoma and BRAF mutations By Staff Reports 5 months ago In a Phase II trial led by researchers at The University of Texas MD Anderson
Biotechnology Coronavirus Coronavirus COVID-19 drug development UCI scientists get ‘initial hit’ in developing drug to treat COVID-19 By Staff Reports 5 months ago When the coronavirus pandemic hit, almost everyone at the University of California, Irvine – and
Biotech Company News Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 Vaccines CEL-SCI Announced Early Results with COVID 19 LEAPS Vaccine/Treatment By Staff Reports 6 months ago CEL-SCI Corporation announces that it has concluded animal experiments using its LEAPS COVID 19 conjugate
Biotechnology Coronavirus Coronavirus COVID-19 COVID-19: Patients Improve After Immune-Suppressant Treatment By Staff Reports 6 months ago Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug
Biotechnology genes Ophthalmology Scientists Use Nanoparticle-Delivered Gene Therapy to Inhibit Blinding Eye Disease in Rodents By Staff Reports 7 months ago In experiments in rats and mice, two Johns Hopkins scientists — an engineer and an
Biotechnology Neurodegenerative diseases Neurology Neuroscience Parkinson's Novel pathology could improve diagnosis and treatment of Huntington’s and other diseases By Staff Reports 7 months ago Bristol scientists have discovered a novel pathology that occurs in several human neurodegenerative diseases, including
Biotechnology Clinical Trials Coronavirus rare diseases How the coronavirus could be prevented from invading a host cell By Staff Reports 8 months ago How might the novel coronavirus be prevented from entering a host cell in an effort
Biotechnology cancer Clinical Trials drug development New chemotherapy drug studied for malignant brain tumor in children By Staff Reports 8 months ago MTX110 is a new formulation of panobinostat, a chemotherapy drug that has shown promise in
Biotechnology Clinical Trials Coronavirus Coronavirus COVID-19 UCLA launches clinical trial to help reduce severity of COVID-19 By Staff Reports 8 months ago UCLA researchers have launched a new clinical trial that uses a hormone suppresser commonly used
Biotechnology Epidemiology Immunotherapies Infection Control Infectious Diseases rare diseases New antigen test for detecting COVID-19 could help triage patients during the pandemic By Staff Reports 8 months ago COVID-19 Ag Respi-Strip test can identify an infected person in 15 minutes at point-of-care sites
Biotechnology Diabetes Uncategorized Smart Contact Lenses that Diagnose and Treat Diabetes By Staff Reports 9 months ago Diabetes is called an incurable disease because once it develops, it does not disappear regardless
Biotechnology cancer Clinical Trials Immunotherapies Boost immune cells’ ability to kill cancer using “Backpacks”? By Staff Reports 9 months ago Macrophages are immune cells that patrol the body looking for potential threats like viruses, bacteria,
Biotechnology Clinical Trials Coronavirus drug development rare diseases Clinical trial in COVID-19 patients tests anti-inflammatory drug developed 25 years ago at Scripps Research By Staff Reports 9 months ago An anti-inflammatory drug developed at Scripps Research 25 years ago is now being tested as